The spectrum of vasculitis in children

Best Practice and Research: Clinical Rheumatology

Volumn 16, Issue 3, 2002, Pages 411-425

  Ozen, S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Child; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN A1; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; PROSTACYCLIN; SALAZOSULFAPYRIDINE; STEROID; SUCRALFATE; THALIDOMIDE; TUBERCULOSTATIC AGENT; INTERFERON;

ANAPHYLACTOID PURPURA; ANTIBIOTIC PROPHYLAXIS; AORTA ARCH SYNDROME; BEHCET DISEASE; CHILD; CHILDHOOD; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; GASTROINTESTINAL DISEASE; GONADAL DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; KIDNEY DISEASE; LABORATORY DIAGNOSIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; REVIEW; SIDE EFFECT; VASCULITIS; WEGENER GRANULOMATOSIS; ABDOMINAL PAIN; CHILDHOOD DISEASE; DIGESTIVE SYSTEM PERFORATION; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; INTESTINE INTUSSUSCEPTION; LABORATORY TEST; PROTEINURIA; SKIN DEFECT; PATHOLOGY;

BEHCET SYNDROME; CHILD; HUMANS; POLYARTERITIS NODOSA; PURPURA, SCHOENLEIN-HENOCH; TAKAYASU'S ARTERITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0036653246     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6942(02)90237-8     Document Type: Review

References (51)

1. Athreya BH. Vasculitis in children. Pediatric Clinics of North America 1995; 42: 1239-1261.
2. Cassidy J & Petty RE. Vasculitis. In Cassidy JT & Petty RE (eds) Textbook of Pediatric Rheumatology, 3rd edn, pp 365-422. Philadelphia: WB Saunders Co, 1995.
3. Jennette JC, Falk J, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis and Rheumatism 1994; 37: 187-192.
4. Allen DM, Diamond LK & Howell DA. Anaphylactoid purpura in children. American Journal of Disease in Childhood 1960; 99: 833-854.
5. Saulsbury FT. Henoch-Schönlein purpura. Current Opinion in Rheumatology 2001; 13: 35-40.
6. Al-Sheyyab M, Batieha A, El-Shanti H & Daoud A. Henoch-Schönlein purpura and streptococcal infection: A prospective case-control study. Annals of Tropical Medicine 1999; 19: 253-255.
7. Calabrese LH, Michel BA, Bloch DA et al. The ACR criteria for the classification of hypersensitivity vasculitis. Arthritis and Rheumatism 1990; 33: 1108-1113.
8. Koskimies O, Rapola J, Savilakti E & Vilska A. Renal involvement in Schönlein-Henoch purpura. Acta Pediatrica Scandinavica 1974; 63: 357-363.
9. Niaudet P & Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatric Nephrology 1998; 12: 238-243.
10. Szer IS. Henoch-Schönlein purpura: When and how to treat. Journal of Rheumatology 1996; 23: 1661-1665.
11. Padeh S & Passwell JH. Successful treatment of chronic Henoch Schoinlein purpura with colchicine and aspirin. Israel Medical Association Journal 2000; 2: 482-483.
12. Oner A, Tinaztepe K & Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch Schoinlein nephritis. Pediatric Nephrology 1995; 9: 6-10.
13. Foster BJ, Bernard C, Drummond KN & Sharma AK. Effective therapy for severe HSP. Journal of Pediatrics 2000; 136: 370-375.
14. Mollica F, Li Volta S, Garozzo R & Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. European Journal of Pediatrics 1992; 151: 140-144.
15. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in HSP. Pediatric Nephrology 1993; 7: 69-71.
16. Guillevin L, Lhote F, Amoroux J et al. ANCA, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg Strauss syndrome. British Journal of Rheumatology 1996; 35: 958-964.
17. Watts RA & Scott DG. Classification and epidemiology of the vasculitides. Baillières Clinical Rheumatology 1997; 11: 191-217.
18. Dillon M. Primary vasculitis in children. In Maddison PJ, Isenberg DA, Woo P & Glass DN (eds) Oxford Textbook of Rheumatology, pp 1402-1412. Oxford: Oxford University Press, 1998.
19. Ozen S, Besbas N, Saatci U & Bakkaloglu A. Diagnostic criteria for polyarteritis nodosa in childhood. Journal of Pediatrics 1992; 2: 206-209.
20. David J, Ansell BM & Woo P. Polyarteritis nodosa associated with streptococcus. Archives of Disease in Childhood 1993; 69: 685-688.
21. Bont K, Brus F, Dijkman-Neerincx RH et al. The clinical spectrum of post-streptococcal syndrome with arthritis in children. Clinical and Experimental Rheumatology 1998; 16: 750-752.
22. Tonnelier JM, Ansart S, Tilly-Gentric A & Pennec YL. Juvenile relapsing periarteritis nodosa and streptococcal infection. Joint Bone Spine 2000; 67: 346-348.
23. Ozen S. Vasculopathy, Behçet's disease and familial Mediterranean fever. Current Opinion in Rheumatology 1999; 11: 393-398.
24. Lightfoor RW Jr, Michel BA, Bloch DA et al. The ACR 1990 criteria for the classification of polyarteritis nodosa. Arthritis and Rheumatism 1990; 33: 1088.
25. Fink CW. Polyarteritis and other diseases with necrotizing vasculitis in childhood. Arthritis and Rheumatism 1997; 20: 378-384.
26. Bakkaloglu A, Ozen S, Baskin E et al. The significance of ANCA in microscopic polyangiitis and classic polyarteritis nodosa. Archives of Disease in Childhood 2001; 85: 427-430.
27. Besbas N, Ozen S, Saatci U et al. Renal involvement in PAN: Evaluation of 25 Turkish children. Pediatric Nephrology 2000; 14: 325-327.
28. Ozen S, Ben-Chetrit E, Bakkaloglu A et al. Polyarteritis nodosa associated with familial Mediterranean fever: Is it an association. Seminars in Arthritis and Rheumatism 2001; 30: 281-287.
29. Wong S-N, Shah V & Dillon MJ. ANCA in childhood systemic vasculitis. Journal of the American Society of Nephrology 1992; 3: 668.
30. Dillon MJ & Tizard EJ. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies. Pediatric Nephrology 1991; 5: 256-259.
31. Jayne D. Update on the European vasculitis study group trials. Current Opinion in Rheumatology 2001; 13: 48-55.
32. Jayne DRW, Gaskin G, (EUVAS) TEVSG. Randomized trial of cyclophosphamide versus azathioprine during remission in ANCA associated vasculitis. Journal of the American Society of Nephrology 1999; 10: 105A.
33. Latta K, Von Schnakenburg C & Ehrich JHH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatric Nephrology 2001; 16: 271-282.
34. Kerr GS. Takayasu's arteritis. Rheumatic Disease Clinics of North America 1995; 21: 1041-1058.
35. Hahn D, Thomson PD, Kala U et al. A review of Takayasu's arteritis in children in Gauteng, South Africa. Pediatric Nephrology 1998; 12: 668-675.
36. Arend WP, Michel BA, Bloch DA et al. The ACR 1990 criteria for the classification of Takayasu arteritis. Arthritis and Rheumatism 1990; 33: 1129-1134.
37. Yamada I, Nakagawa T, Himeno Y et al. Takayasu arteritis: Diagnosis with breath hold contrast enhanced 3-dimensional MR angiography. Journal of Magnetic Resonance Imaging 2000; 11: 481-487.
38. Hoffman GS, Leavitt RY, Kerr GS et al. Treatment of glucocorticoid resistant or relapsing Takayasu arteritis with methotrexate. Arthritis and Rheumatism 1994; 37: 578-582.
39. Rottem M, Fauci AS, Hallahan CW et al. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. Journal of Pediatrics 1993; 122: 26.
40. Leavitt RY, Fauci AS, Blach DA et al. The ACR 1990 criteria for the classification of Wegener's granulomatosis. Arthritis and Rheumatism 1990; 33: 1101.
41. McHugh K, Manson D, Eberhard BA et al. WG in childhood. Pediatric Radiology 1991; 21: 552-555.
42. Stegmayer BG, Gothefors L, Malmer B et al. WG in children and young adults. A case study of 10 patients. Pediatric Nephrology 2000; 14: 208-213.
43. Aasarod K, Iversen BM, Hammerstrom J et al. Wegener's granulomatosis: Clinical course in 108 patients with renal involvement. Nephrology Dialysis Transplantation 2000; 15: 611-618.
44. Yazici H, Yurdakul S & Hamuryudan V. Behçet's syndrome. Current Opinion in Rheumatology 2001; 13: 518-522.
45. Ehrlich GE. Behçet disease and the emergence of thalidomide. Annals of Internal Medicine 1998; 128: 494-495.
46. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1070-1080.
47. Kone-Paut I, Yurdakul S, Bahabri SA et al. Epidemiological features of Behçet's syndrome in children: An international collaborative survey of 86 cases. Journal of Pediatrics 1998; 132: 721-725.
48. Uziel Y, Brik R, Padeh S et al. Juvenile Behçet's syndrome in Israel. Clinical and Experimental Rheumatology 1998; 16: 502-505.
49. Kaneko F, Oyama N & Nisibu A. Streptococcal infection in the pathogenesis of Behçet's syndrome and clinical effects of minocycline on the disease symptoms. Yonsei Medical Journal 1997; 38: 444-454.
50. Calguneri M, Ertenli I, Kiraz S et al. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease. Dermatology 1996; 192: 125-128.
51. Schirmer M, Calamia KT & Direskeneli H. International Conference on Behçet's disease: Seoul, Korea, 2000. Journal of Rheumatology 2000; 28: 636-639.